ArticleBiomedicines2022

Estimating the Prevalence of De Novo Monogenic Neurodevelopmental Disorders from Large Cohort Studies.

Madelyn A Gillentine et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.